3.20.2 html 164 276 1 false 52 0 false 4 false false R1.htm 1001 - Document - Cover Page Sheet http://www.checkmatepharma.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Balance Sheets Sheet http://www.checkmatepharma.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.checkmatepharma.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Statements of Operations And Comprehensive Loss Sheet http://www.checkmatepharma.com/role/CondensedStatementsOfOperationsAndComprehensiveLoss Condensed Statements of Operations And Comprehensive Loss Statements 4 false false R5.htm 1005 - Statement - Condensed Statements of Redeemable Convertible Preferred Stock And Stockholders' Deficit Sheet http://www.checkmatepharma.com/role/CondensedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficit Condensed Statements of Redeemable Convertible Preferred Stock And Stockholders' Deficit Statements 5 false false R6.htm 1006 - Statement - Condensed Statements of Redeemable Convertible Preferred Stock And Stockholders' Deficit (Parenthetical) Sheet http://www.checkmatepharma.com/role/CondensedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitParenthetical Condensed Statements of Redeemable Convertible Preferred Stock And Stockholders' Deficit (Parenthetical) Statements 6 false false R7.htm 1007 - Statement - Condensed Statements of Cash Flows Sheet http://www.checkmatepharma.com/role/CondensedStatementsOfCashFlows Condensed Statements of Cash Flows Statements 7 false false R8.htm 1008 - Disclosure - Nature of Business And Basics of Presentation Sheet http://www.checkmatepharma.com/role/NatureOfBusinessAndBasicsOfPresentation Nature of Business And Basics of Presentation Notes 8 false false R9.htm 1009 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.checkmatepharma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 1010 - Disclosure - Fair Value Measurement Sheet http://www.checkmatepharma.com/role/FairValueMeasurement Fair Value Measurement Notes 10 false false R11.htm 1011 - Disclosure - Accrued Expenses Sheet http://www.checkmatepharma.com/role/AccruedExpenses Accrued Expenses Notes 11 false false R12.htm 1012 - Disclosure - Convertible Loan Notes Notes http://www.checkmatepharma.com/role/ConvertibleLoanNotes Convertible Loan Notes Notes 12 false false R13.htm 1013 - Disclosure - Redeemable Convertible Preferred Stock Sheet http://www.checkmatepharma.com/role/RedeemableConvertiblePreferredStock Redeemable Convertible Preferred Stock Notes 13 false false R14.htm 1014 - Disclosure - Common Stock Sheet http://www.checkmatepharma.com/role/CommonStock Common Stock Notes 14 false false R15.htm 1015 - Disclosure - Stock based compensation Sheet http://www.checkmatepharma.com/role/StockBasedCompensation Stock based compensation Notes 15 false false R16.htm 1016 - Disclosure - Income taxes Sheet http://www.checkmatepharma.com/role/IncomeTaxes Income taxes Notes 16 false false R17.htm 1017 - Disclosure - Net Loss Per Share Sheet http://www.checkmatepharma.com/role/NetLossPerShare Net Loss Per Share Notes 17 false false R18.htm 1018 - Disclosure - Commitments And Contingencies Sheet http://www.checkmatepharma.com/role/CommitmentsAndContingencies Commitments And Contingencies Notes 18 false false R19.htm 1019 - Disclosure - Subsequent Events Sheet http://www.checkmatepharma.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 1020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.checkmatepharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.checkmatepharma.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 1021 - Disclosure - Fair Value Measurement (Tables) Sheet http://www.checkmatepharma.com/role/FairValueMeasurementTables Fair Value Measurement (Tables) Tables http://www.checkmatepharma.com/role/FairValueMeasurement 21 false false R22.htm 1022 - Disclosure - Accrued Expenses (Tables) Sheet http://www.checkmatepharma.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.checkmatepharma.com/role/AccruedExpenses 22 false false R23.htm 1023 - Disclosure - Redeemable Convertible Preferred Stock (Tables) Sheet http://www.checkmatepharma.com/role/RedeemableConvertiblePreferredStockTables Redeemable Convertible Preferred Stock (Tables) Tables http://www.checkmatepharma.com/role/RedeemableConvertiblePreferredStock 23 false false R24.htm 1024 - Disclosure - Common Stock (Tables) Sheet http://www.checkmatepharma.com/role/CommonStockTables Common Stock (Tables) Tables http://www.checkmatepharma.com/role/CommonStock 24 false false R25.htm 1025 - Disclosure - Stock based compensation - (Tables) Sheet http://www.checkmatepharma.com/role/StockBasedCompensationTables Stock based compensation - (Tables) Tables http://www.checkmatepharma.com/role/StockBasedCompensation 25 false false R26.htm 1026 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.checkmatepharma.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.checkmatepharma.com/role/NetLossPerShare 26 false false R27.htm 1027 - Disclosure - Nature of Business And Basics of Presentation - Additional Information (Detail) Sheet http://www.checkmatepharma.com/role/NatureOfBusinessAndBasicsOfPresentationAdditionalInformationDetail Nature of Business And Basics of Presentation - Additional Information (Detail) Details 27 false false R28.htm 1028 - Disclosure - Fair Value Measurement - Schedule of Fair Value Assets And Liabilities Measured On Recurring Basis (Detail) Sheet http://www.checkmatepharma.com/role/FairValueMeasurementScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail Fair Value Measurement - Schedule of Fair Value Assets And Liabilities Measured On Recurring Basis (Detail) Details 28 false false R29.htm 1029 - Disclosure - Fair Value Measurement - Schedule of Aggregate Fair Value of The Company's Series B Preferred Stock Tranche Right Liability (Detail) Sheet http://www.checkmatepharma.com/role/FairValueMeasurementScheduleOfAggregateFairValueOfTheCompanysSeriesBPreferredStockTrancheRightLiabilityDetail Fair Value Measurement - Schedule of Aggregate Fair Value of The Company's Series B Preferred Stock Tranche Right Liability (Detail) Details 29 false false R30.htm 1030 - Disclosure - Fair Value Measurement - Schedule of Fair Value, Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation (Detail) Sheet http://www.checkmatepharma.com/role/FairValueMeasurementScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetail Fair Value Measurement - Schedule of Fair Value, Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation (Detail) Details 30 false false R31.htm 1031 - Disclosure - Fair Value Measurement - Additional Information (Details) Sheet http://www.checkmatepharma.com/role/FairValueMeasurementAdditionalInformationDetails Fair Value Measurement - Additional Information (Details) Details 31 false false R32.htm 1032 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail) Sheet http://www.checkmatepharma.com/role/AccruedExpensesScheduleOfAccruedExpensesDetail Accrued Expenses - Schedule of Accrued Expenses (Detail) Details 32 false false R33.htm 1033 - Disclosure - Convertible Loan Notes - Additional Information (Detail) Notes http://www.checkmatepharma.com/role/ConvertibleLoanNotesAdditionalInformationDetail Convertible Loan Notes - Additional Information (Detail) Details 33 false false R34.htm 1034 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Detail) Sheet http://www.checkmatepharma.com/role/RedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetail Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Detail) Details 34 false false R35.htm 1035 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Cumulative Dividends (Detail) Sheet http://www.checkmatepharma.com/role/RedeemableConvertiblePreferredStockScheduleOfCumulativeDividendsDetail Redeemable Convertible Preferred Stock - Schedule of Cumulative Dividends (Detail) Details 35 false false R36.htm 1036 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Detail) Sheet http://www.checkmatepharma.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail Redeemable Convertible Preferred Stock - Additional Information (Detail) Details 36 false false R37.htm 1037 - Disclosure - Common Stock - Summary of Common Stock Available for Future Issuance (Detail) Sheet http://www.checkmatepharma.com/role/CommonStockSummaryOfCommonStockAvailableForFutureIssuanceDetail Common Stock - Summary of Common Stock Available for Future Issuance (Detail) Details 37 false false R38.htm 1038 - Disclosure - Stock based compensation - Schedule of fair value of stock option awards on the grant date using the Black-Scholes option valuation model (Detail) Sheet http://www.checkmatepharma.com/role/StockBasedCompensationScheduleOfFairValueOfStockOptionAwardsOnTheGrantDateUsingTheBlackScholesOptionValuationModelDetail Stock based compensation - Schedule of fair value of stock option awards on the grant date using the Black-Scholes option valuation model (Detail) Details 38 false false R39.htm 1039 - Disclosure - Stock based compensation - Summary the activity under the Company's stock option plan (Detail) Sheet http://www.checkmatepharma.com/role/StockBasedCompensationSummaryTheActivityUnderTheCompanySStockOptionPlanDetail Stock based compensation - Summary the activity under the Company's stock option plan (Detail) Details 39 false false R40.htm 1040 - Disclosure - Stock based compensation - Summary of total stock-based compensation expense (Details) Sheet http://www.checkmatepharma.com/role/StockBasedCompensationSummaryOfTotalStockBasedCompensationExpenseDetails Stock based compensation - Summary of total stock-based compensation expense (Details) Details 40 false false R41.htm 1041 - Disclosure - Stock based compensation - Additional information (Detail) Sheet http://www.checkmatepharma.com/role/StockBasedCompensationAdditionalInformationDetail Stock based compensation - Additional information (Detail) Details 41 false false R42.htm 1042 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.checkmatepharma.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 42 false false R43.htm 1043 - Disclosure - Net Loss Per Share - Summary of Basic And Diluted Net Loss Per Share Attributable To Common Stockholders (Detail) Sheet http://www.checkmatepharma.com/role/NetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetail Net Loss Per Share - Summary of Basic And Diluted Net Loss Per Share Attributable To Common Stockholders (Detail) Details 43 false false R44.htm 1044 - Disclosure - Net Loss Per Share - Summary of Potentially Dilutive Shares Excluded From The Calculation of Diluted Net Loss (Detail) Sheet http://www.checkmatepharma.com/role/NetLossPerShareSummaryOfPotentiallyDilutiveSharesExcludedFromTheCalculationOfDilutedNetLossDetail Net Loss Per Share - Summary of Potentially Dilutive Shares Excluded From The Calculation of Diluted Net Loss (Detail) Details 44 false false R45.htm 1045 - Disclosure - Commitments And Contingencies - Additional information (Detail) Sheet http://www.checkmatepharma.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments And Contingencies - Additional information (Detail) Details 45 false false R46.htm 1046 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.checkmatepharma.com/role/SubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 46 false false All Reports Book All Reports cmpi-20200630.xml cmpi-20200630.xsd cmpi-20200630_cal.xml cmpi-20200630_def.xml cmpi-20200630_lab.xml cmpi-20200630_pre.xml http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2020-01-31 true true